Albert R. Taxin Golf & Bridge Classic Celebrates 17th Anniversary

Albert R. Taxin Golf & Bridge Classic Celebrates 17th Anniversary

May 23, 2012

PHILADELPHIA – (May 23, 2012) –The 17th annual Albert R. Taxin Golf & Bridge Classic raised more than $180,000 (gross) this year to advance brain tumor research at the Albert R. Taxin Brain Tumor Research Center at The Wistar Institute. The Classic, which included an American Contract Bridge League-sanctioned bridge tournament, was held May 21 at Green Valley Country Club, in Lafayette Hill, Pa.

More than 180 friends and supporters of The Wistar Institute participated in the event, including 2012 event co-chairs Fran Tobin and Dan Fitzpatrick, President & CEO, Citizens Bank of PA/NJ/DE; founder and honorary chair Doris Taxin; and Wistar President and CEO Russel E. Kaufman, M.D.

This event was established to honor the memory and legacy of Albert R. Taxin, a beloved Philadelphian who died in 1993 of a brain tumor. Taxin was the long-time proprietor of Old Original Bookbinder’s restaurant. Since its inception, the Taxin Classic has raised $1.8 million for brain tumor research at Wistar.

Current treatment options for brain tumor patients are largely ineffective and can cause debilitating side effects. At The Wistar Institute, researchers are studying tumors at the molecular level to develop better targeted therapies that may improve the quality of life for tens of thousands of people diagnosed with brain cancer each year. Learn more about Wistar’s cancer research here.

The 17th annual Albert R. Taxin Golf & Bridge Classic was made possible in part by support from generous donors including the Reuben and Mollie Gordon Foundation, Bob and Penny Fox, Fran and Sylvan Tobin, Citizens Bank, Ron and Marcia Rubin, Doris Taxin, Peggy and Doug Briggs, Stephen A. Cozen, the Jill and Mark Fishman Foundation, Sharon and Joseph Kestenbaum, and Dan Wheeler and Amy Fox.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the Web at www.wistar.org.

FOR IMMEDIATE RELEASE: Wednesday, May 23, 2012                         

Contact: Alayna Avery, (215) 898-3790                              

###